《瑞德西韦的修正：对其发现与研发历程的回顾，该历程导向了针对治疗 COVID-19 的人体临床试验》
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19.
作者信息
Eastman Richard T, Roth Jacob S, Brimacombe Kyle R, Simeonov Anton, Shen Min, Patnaik Samarjit, Hall Matthew D
出版信息
ACS Cent Sci. 2020 Jun 24;6(6):1009. doi: 10.1021/acscentsci.0c00747. Epub 2020 Jun 16.
Abstract
[This corrects the article DOI: 10.1021/acscentsci.0c00489.].
摘要
[本文更正了文章的数字对象标识符：10.1021/acscentsci.0c00489。]
相似文献
1
Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19.
ACS Cent Sci. 2020 Jun 24;6(6):1009. doi: 10.1021/acscentsci.0c00747. Epub 2020 Jun 16.
2
The journey of remdesivir: from Ebola to COVID-19.
Drugs Context. 2020 May 22;9. doi: 10.7573/dic.2020-4-14. eCollection 2020.
3
Correction to "An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with Efficacy against Drug-Resistant Gram-Negative Infections".
ACS Cent Sci. 2022 Sep 28;8(9):1362. doi: 10.1021/acscentsci.2c00969. Epub 2022 Sep 6.
4
Correction to "Molecular Caging of Graphene with Cyclohexane: Transfer and Electrical Transport".
ACS Cent Sci. 2018 May 23;4(5):661. doi: 10.1021/acscentsci.8b00227. Epub 2018 Apr 25.
5
Correction to Chemical Fingerprint of Zn-Hydroxyapatite in the Early Stages of Osteogenic Differentiation.
ACS Cent Sci. 2019 Oct 23;5(10):1731. doi: 10.1021/acscentsci.9b00918. Epub 2019 Oct 15.
6
Correction to Rational Design of Fluorogenic and Spontaneously Blinking Labels for Super-Resolution Imaging.
ACS Cent Sci. 2020 Oct 28;6(10):1844. doi: 10.1021/acscentsci.0c01119. Epub 2020 Sep 16.
7
Correction to "Synthetic Elaboration of Native DNA by RASS (SENDR)".
ACS Cent Sci. 2020 Nov 25;6(11):2117. doi: 10.1021/acscentsci.0c01389. Epub 2020 Oct 23.
8
Correction to "Assessing Physicochemical Properties of Drug Molecules via Microsolvation Measurements with Differential Mobility Spectrometry".
ACS Cent Sci. 2017 Apr 26;3(4):359. doi: 10.1021/acscentsci.7b00106. Epub 2017 Mar 15.
9
Correction to Overcoming Ovarian Cancer Drug Resistance with a Cold Responsive Nanomaterial.
ACS Cent Sci. 2021 May 26;7(5):909. doi: 10.1021/acscentsci.1c00530. Epub 2021 May 17.
10
Correction to "Accurate Representations of the Microphysical Processes Occurring during the Transport of Exhaled Aerosols and Droplets".
ACS Cent Sci. 2021 Mar 24;7(3):507. doi: 10.1021/acscentsci.1c00220. Epub 2021 Feb 26.
引用本文的文献
1
Exploring TMPRSS2 Drug Target to Combat Influenza and Coronavirus Infection.
Scientifica (Cairo). 2025 Apr 21;2025:3687892. doi: 10.1155/sci5/3687892. eCollection 2025.
2
Universal and divergent P-stereogenic building with camphor-derived 2,3-diols.
Commun Chem. 2023 Jun 27;6(1):133. doi: 10.1038/s42004-023-00935-0.
3
Antiviral Lipid Nanocarrier Loaded with Remdesivir Effective Against SARS-CoV-2 in vitro Model.
Int J Nanomedicine. 2023 Mar 27;18:1561-1575. doi: 10.2147/IJN.S391462. eCollection 2023.
4
Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals.
Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0170322. doi: 10.1128/aac.01703-22. Epub 2023 Mar 28.
5
Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets.
Cells. 2021 Sep 15;10(9):2427. doi: 10.3390/cells10092427.
6
Encapsulated hydroxychloroquine and chloroquine into cyclic oligosaccharides are the potential therapeutics for COVID-19: insights from first-principles calculations.
J Mol Struct. 2022 Jan 5;1247:131371. doi: 10.1016/j.molstruc.2021.131371. Epub 2021 Aug 26.
7
Evaluation of the Treatment Efficacy and Safety of Remdesivir for COVID-19: a Meta-analysis.
SN Compr Clin Med. 2021;3(12):2443-2454. doi: 10.1007/s42399-021-01014-y. Epub 2021 Aug 7.
8
Analysis of COVID-19 on Diagnosis, Vaccine, Treatment, and Pathogenesis with Clinical Scenarios.
Clin Pract. 2021 May 19;11(2):309-321. doi: 10.3390/clinpract11020044.
9
Adenosine-related small molecules show utility of recall antigen assay to screen compounds for off-target effects on memory T cells.
Sci Rep. 2021 May 5;11(1):9561. doi: 10.1038/s41598-021-88965-3.
10
Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview.
Pharmacol Res Perspect. 2021 Feb;9(1):e00705. doi: 10.1002/prp2.705.
本文引用的文献
1
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies.
Nat Commun. 2018 Oct 1;9(1):4013. doi: 10.1038/s41467-018-06215-z.
2
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
mBio. 2018 Mar 6;9(2):e00221-18. doi: 10.1128/mBio.00221-18.
3
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
Nature. 2016 Mar 17;531(7594):381-5. doi: 10.1038/nature17180. Epub 2016 Mar 2.
Zotero 插件